Association between hepatitis B virus and MHC class I polypeptide-related chain A in human hepatocytes derived from human-mouse chimeric mouse liver.

[1]  O. Yokosuka,et al.  Reappearance of serum hepatitis B viral DNA in patients with hepatitis B surface antigen seroclearance , 2015, Hepatology.

[2]  C. Seeger,et al.  Molecular biology of hepatitis B virus infection. , 2015, Virology.

[3]  K. Chayama,et al.  Novel robust in vitro hepatitis B virus infection model using fresh human hepatocytes isolated from humanized mice. , 2015, The American journal of pathology.

[4]  N. Kato,et al.  MICA SNPs and the NKG2D system in virus-induced HCC , 2015, Journal of Gastroenterology.

[5]  A. Lok,et al.  Recent US Food and Drug Administration warnings on hepatitis B reactivation with immune‐suppressing and anticancer drugs: Just the tip of the iceberg? , 2015, Hepatology.

[6]  A. Tamori,et al.  Discovering novel direct acting antiviral agents for HBV using in silico screening. , 2015, Biochemical and biophysical research communications.

[7]  O. Yokosuka,et al.  Reactivation of Hepatitis B Virus in Hematopoietic Stem Cell Transplant Recipients in Japan: Efficacy of Nucleos(t)ide Analogues for Prevention and Treatment , 2014, International journal of molecular sciences.

[8]  K. Meyer,et al.  Hepatitis C Virus Impairs Natural Killer Cell-Mediated Augmentation of Complement Synthesis , 2013, Journal of Virology.

[9]  P. Kremsner,et al.  Hepatitis B virus‐induced hepatocellular carcinoma: functional roles of MICA variants , 2013, Journal of viral hepatitis.

[10]  J. Kao,et al.  Risk stratification for hepatitis B virus related hepatocellular carcinoma , 2013, Journal of gastroenterology and hepatology.

[11]  Yusuke Nakamura,et al.  Soluble MICA and a MICA Variation as Possible Prognostic Biomarkers for HBV-Induced Hepatocellular Carcinoma , 2012, PloS one.

[12]  O. Yokosuka,et al.  Hepatitis B virus e antigen physically associates with receptor-interacting serine/threonine protein kinase 2 and regulates IL-6 gene expression. , 2012, The Journal of infectious diseases.

[13]  M. Takamura,et al.  Reduced NKG2D ligand expression in hepatocellular carcinoma correlates with early recurrence. , 2012, Journal of hepatology.

[14]  Yusuke Nakamura,et al.  Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma , 2011, Nature Genetics.

[15]  O. Yokosuka,et al.  Hepatitis B virus e antigen downregulates cytokine production in human hepatoma cell lines. , 2010, Viral immunology.

[16]  M. Ait-goughoulte,et al.  Innate Antiviral Immune Responses to Hepatitis B Virus , 2010, Viruses.

[17]  J. Xie,et al.  Inhibition of hepatitis B virus replication by small interference RNA induces expression of MICA in HepG2.2.15 cells , 2009, Medical Microbiology and Immunology.

[18]  A. Lohse,et al.  Virion half‐life in chronic hepatitis B infection is strongly correlated with levels of viremia , 2008, Hepatology.

[19]  N. Izumi,et al.  Influence of hepatitis B virus genotypes on the intra‐ and extracellular expression of viral DNA and antigens , 2006, Hepatology.

[20]  Roberta Castriconi,et al.  Surface NK receptors and their ligands on tumor cells. , 2006, Seminars in immunology.

[21]  T. Asahara,et al.  Growth and differentiation of colony-forming human hepatocytes in vitro. , 2006, Journal of hepatology.

[22]  J. Goedert,et al.  MICA and recovery from hepatitis C virus and hepatitis B virus infections , 2004, Genes and Immunity.

[23]  Christian Trepo,et al.  Infection of a human hepatoma cell line by hepatitis B virus , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[24]  R. Armitage,et al.  ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. , 2001, Immunity.

[25]  A Steinle,et al.  Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. , 1999, Science.

[26]  O. Yokosuka,et al.  Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis. , 1991, The New England journal of medicine.

[27]  O. Yokosuka,et al.  Hepatitis B virus RNA transcripts and DNA in chronic liver disease. , 1986, The New England journal of medicine.